Bifidobacterium bifidum

Condiciones de salud que Bifidobacterium bifidum puede ayudar a apoyar.

• DislocaciónCientífico

  Bifidobacterium bifidum MIMBb75 reduced global IBS symptoms, abdominal pain, discomfort, distension, and bloating in a 4-week RCT (n=122 patients) with responder rates of 57% versus 21% for placebo. It is one of the most strain-specifically studied Bifidobacterium species for abdominal discomfort.

• Acidez EstomacalCientífico

  Preclinical studies show B. bifidum supplementation improves anxiety-like behavior in rodents subjected to chronic intestinal inflammation. Genus-level evidence from epidemiological and interventional studies links Bifidobacterium abundance to stress and anxiety outcomes via gut-brain axis pathways. B. bifidum specifically has been noted in rodent models for anxiolytic effects.

• Fatiga SuprarrenalCientífico

  B. bifidum has been shown in animal models to reduce insulin resistance and improve lipid profiles in diabetic conditions, and synbiotic supplements including B. bifidum improved insulin metabolism and HDL-cholesterol in overweight T2DM patients with coronary heart disease in a human trial. Mechanisms include modulation of gut microbiota, FXR expression, and hepatic lipid regulation.

• Contaminación AmbientalCientífico

  Bifidobacterium bifidum IATA-ES2 is specifically identified in in vitro studies as protecting against gliadin-induced inflammatory response and mucosal damage in celiac disease models, reducing IFN-γ and TNF-α while increasing IL-10. These findings are cited in the PMC 2020 systematic review and the 2025 PubMed review of Bifidobacteria in CeD. IATA-ES2 is among the most mechanistically characterized strains in celiac disease probiotic research.

• AnorexiaCientífico

  Bifidobacterium bifidum has been evaluated as part of probiotic combinations for infant and childhood allergy prevention. It was included in perinatal probiotic supplementation trials that demonstrated reduced prevalence of early atopic dermatitis. Mechanistic research shows B. bifidum FN120 utilizes 2'-fucosyllactose via cross-feeding to reshape gut microbiota and prevent atopic dermatitis in experimental models.

• Antibióticos (efectos secundarios de los)Científico

  Bifidobacterium bifidum is a key early-colonizing Bifidobacterium in the infant gut and has been used clinically to prevent diarrhea in hospitalized infants. A landmark 1994 Lancet RCT showed that feeding B. bifidum and Streptococcus thermophilus to hospitalized infants prevented diarrhea and rotavirus shedding. It is included in pediatric probiotic guidelines for select GI indications.

• AnsiedadCientífico

  Bifidobacterium bifidum is a clinically studied probiotic strain for children's immune and respiratory health. In combination with other Lactobacillus and Bifidobacterium strains, B. bifidum supplementation was shown to prevent URTIs and reduce antibiotic use in preschool children. It is a component of the ProbioKid formulation shown to decrease respiratory infection rates in children supplemented for 3–9 months.

• Válvula IleocecalCientífico

  B. bifidum strain PRL2010 has demonstrated cholesterol-lowering activity in vitro and in a murine model, with transcriptomic evidence of specific cholesterol assimilation mechanisms and conversion of cholesterol to coprostanol. Genus-level human data also link Bifidobacterium-containing probiotics to reductions in total cholesterol and LDL in metabolic disease patients.

• ApendicitisCientífico

  B. bifidum modulates both innate and adaptive immune responses to attenuate chronic inflammatory signaling. It promotes anti-inflammatory cytokine environments, including increased IL-10 and TGF-β expression in dendritic cells, and converts dietary vitamin A to retinoic acid to support immunological tolerance. Preclinical evidence is strong; human anti-inflammatory endpoints have been measured in IBS and metabolic disease trials.

• Estrógeno (bajo)Científico

  Bifidobacterium bifidum is included in multi-strain probiotic formulations (including VSL#3 predecessor formulations) that have demonstrated benefit for ulcerative colitis and pouchitis in RCTs. Systematic reviews confirm Bifidobacteria including B. bifidum contribute to UC treatment and maintenance of remission.

• ArtritisCientífico

  Bifidobacterium bifidum is a probiotic species included in multi-strain formulations with demonstrated constipation RCT efficacy. It was part of a 4-week RCT (n=94 adults) and a 30-day RCT where probiotic blends containing B. bifidum produced significant improvements in stool frequency and consistency. Meta-analyses of Bifidobacterium-containing probiotic trials confirm reduced gut transit time and increased stool frequency.

• Trastorno por Déficit de AtenciónCientífico

  Bifidobacterium genus preparations, including strains closely related to B. bifidum, have demonstrated antidepressant effects via the gut-brain axis in both animal models and human RCTs. A meta-analysis of RCTs found Bifidobacterium-related preparations effectively improved depressive symptoms. B. bifidum specifically improved anxiety-like behavior induced by chronic intestinal inflammation in rodent models.

• Vista (deficiente)Científico

  Bifidobacterium bifidum has been studied in clinical trials for atopic dermatitis, including in pediatric populations. Systematic reviews on probiotics in AD include B. bifidum strains among those tested, with evidence for immunomodulatory effects on the Th2-skewed immune response in AD.

• Trastornos AutoinmunesCientífico

  Bifidobacterium bifidum has been documented alongside L. acidophilus and S. boulardii in a 12-study meta-analysis showing statistically significant effects on reducing and preventing traveler's diarrhea (P<0.001). It is included in Cochrane reviews of probiotic interventions for diarrhea in children.

• Parálisis de BellCientífico

  Bifidobacterium bifidum has been used in RCTs studying probiotic prevention of eczema in high-risk infants. A double-blind placebo-controlled RCT included B. bifidum BGN4 in a multi-strain combination given prenatally and postpartum to reduce eczema incidence. Multi-strain combinations including B. bifidum have shown significant SCORAD improvements in children.

• Síndrome de DownCientífico

  Bifidobacterium bifidum is among Bifidobacterium species evaluated in probiotic clinical trials for allergic disease in children, including food allergy and atopic dermatitis. It is cited in systematic reviews as part of probiotic regimens demonstrating reduction of allergic sensitization markers and eczema prevalence. Its immunomodulatory effects include regulation of Th1/Th2 balance.

• Enfermedad del Hígado GrasoCientífico

  Bifidobacterium bifidum has been studied as an adjunct probiotic for H. pylori-associated gastritis within multi-strain combinations. It contributes to the inhibitory effects against H. pylori colonization and the reduction of gastric mucosal inflammation seen with Bifidobacterium-Lactobacillus combination protocols.

• Leche materna (secar)Científico

  Bifidobacterium bifidum is a key probiotic species in both infant and adult gut microbiomes, with specialized capacity to degrade human milk oligosaccharides and mucin. It is associated with enhanced gut barrier function, reduced pathogen colonization, and immune modulation in clinical trials.

• Senos (aumentar tamaño)Científico

  Bifidobacterium bifidum has been studied in probiotic formulations targeting gut-brain axis function, including studies in Alzheimer's disease patients where combinations including B. bifidum improved cognitive performance and metabolic profiles. It supports gut barrier integrity and anti-inflammatory signaling relevant to neuropsychiatric health.

• PulgasCientífico

  B. bifidum MIMBb75 is among the best-evidenced single-strain probiotics for IBS. A double-blind, placebo-controlled RCT in 122 IBS patients showed it significantly reduced global IBS symptom scores, abdominal pain, bloating, and improved quality of life versus placebo. A subsequent larger Lancet Gastroenterology trial (443 patients) confirmed benefit even with heat-inactivated bacteria. Overall evidence rates at SORT C due to mixed meta-analytic results when pooling all Bifidobacterium species.

• FlotadoresCientífico

  Bifidobacterium bifidum has demonstrated clinical efficacy in UC in RCTs. It significantly reduced clinical colitis activity indices, improved mucosal histology, and maintained remission in UC patients in controlled trials. It is among the Bifidobacterium strains with strongest evidence in IBD.

• CataratasCientífico

  Bifidobacterium bifidum has been shown in clinical studies to reduce abdominal pain and overall symptom scores in lactose-intolerant adults. A 2023 meta-analysis (Journal of Dairy Science) identified it as one of the effective monostrain probiotics for abdominal pain and total LI symptoms. It produces β-galactosidase that aids colonic lactose metabolism.

• Vesícula Biliar (perezosa o extirpada)Científico

  B. bifidum strain BB1 has been specifically shown to enhance intestinal epithelial tight junction (TJ) barrier function in cell models and animal studies, acting via a Toll-like receptor-2 (TLR-2) pathway. This strain protects against TNF-α-induced permeability increases, offering a mechanistic basis for therapeutic use in leaky gut and inflammatory bowel conditions. Human proof-of-concept trials are in progress.

• Conmociones cerebralesCientífico

  Bifidobacterium bifidum has been studied within the genus context for oral microbiome modulation. The Bifidobacterium genus broadly inhibits periodontopathogens and cariogenic bacteria. B. bifidum is included in formulations studied for oral health and has in vitro evidence for inhibiting S. mutans and oral candida.

• Cabello (pérdida o adelgazamiento)Científico

  Bifidobacterium bifidum is one of the probiotic strains included in multi-strain probiotic RCTs demonstrating improvements in PCOS metabolic, inflammatory, and hormonal parameters. It is among the Bifidobacterium strains cited in comprehensive PCOS probiotic evidence reviews.

• DeshidrataciónCientífico

  Bifidobacterium bifidum was a component of the multi-strain probiotic that demonstrated significantly improved UTI-free survival in a double-blind RCT in 181 children with febrile UTI (96.7% vs. 83.3%, p=0.02). It supports urinary flora indirectly through gut-urinary axis effects, reducing uropathogen reservoir in the gut. It is included in clinically studied urogenital probiotic formulations.

• DermatitisCientífico

  Bifidobacterium bifidum W28 was a component of a multi-strain vaginal capsule that restored Lactobacillus-dominated vaginal microbiota and significantly reduced BV incidence in a clinical study. B. bifidum is listed among well-studied probiotic species for BV and vaginitis treatment, and it has antimicrobial properties against urogenital pathogens.

Sistemas corporales que Bifidobacterium bifidum puede ayudar a apoyar.

• No hay sistemas corporales disponibles.